SCHEMBL31571994

SCHEMBL31571994

O=C(O)CCSc1nc2ccccc2c2cc(CNC(=O)c3ccccc3OC(F)(F)F)nn12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.38
MAPK1 P28482 1/20 0.37
F2R P25116 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HTT P42858 1/20 0.37
EGFR P00533 1/20 0.35
BTK Q06187 1/20 0.35
RECQL P46063 1/20 0.35
SCN9A Q15858 1/20 0.35
SCN10A Q9Y5Y9 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
PTGER4 P35408 1/20 0.35
HCN1 O60741 1/20 0.35
PDPK1 O15530 1/20 0.35
AR P10275 1/20 0.35
ADRA2A P08913 1/20 0.34
NPY5R Q15761 1/20 0.34
MCHR1 Q99705 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26630686 0.93 EGFR (0.37) KMT2AMEN1MAPK1F2RALDH1A1
SCHEMBL26601311 0.92 POLB (0.38) L3MBTL1F2RALDH1A1HTTEGFR
SCHEMBL31675879 0.92 POLB (0.38) L3MBTL1F2RALDH1A1HTTEGFR
Trifluoroacetic Acid SCHEMBL26601324 0.90 EGFR (0.38) KMT2AMEN1F2RALDH1A1HTT
Trifluoroacetic Acid SCHEMBL30623528 0.90 EGFR (0.38) KMT2AMEN1F2RALDH1A1HTT
SCHEMBL31461697 0.88 ALDH1A1 (0.41) KMT2AMEN1L3MBTL1MAPK1F2R
SCHEMBL31461702 0.88 ALDH1A1 (0.41) KMT2AMEN1L3MBTL1MAPK1F2R
SCHEMBL26629775 0.88 ALDH1A1 (0.41) KMT2AMEN1L3MBTL1MAPK1F2R
SCHEMBL31571990 0.87 RORC (0.42) L3MBTL1EGFRBTKPTGDR2PTGER4
SCHEMBL31675875 0.87 ACACB (0.38) ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025090847-A1 ESTROGEN RECEPTOR DEGRADERS AND THEIR USE IN THE TREATMENT OF CANCER BPGBIO, INC. (US) 2025-05-01 WO disclosed